<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Epigenomics | Tanigawa Lab</title><link>https://tanigawalab.org/tags/epigenomics/</link><atom:link href="https://tanigawalab.org/tags/epigenomics/index.xml" rel="self" type="application/rss+xml"/><description>Epigenomics</description><generator>Hugo Blox Builder (https://hugoblox.com)</generator><language>en</language><lastBuildDate>Thu, 13 Nov 2025 00:00:00 +0000</lastBuildDate><image><url>https://tanigawalab.org/media/logo_hu_6ec5cb994dd998e6.png</url><title>Epigenomics</title><link>https://tanigawalab.org/tags/epigenomics/</link></image><item><title>PRISM: ancestry-aware integration of tissue-specific genomic annotations enhances the transferability of polygenic scores</title><link>https://tanigawalab.org/publications/preprint/prism/</link><pubDate>Thu, 13 Nov 2025 00:00:00 +0000</pubDate><guid>https://tanigawalab.org/publications/preprint/prism/</guid><description>&lt;p&gt;Accurate genetic prediction of complex traits has the potential to substantially reduce the disease burden, but the limited transferability of polygenic score (PGS) across genetic ancestry groups remains a major challenge.
&lt;figure &gt;
&lt;div class="flex justify-center "&gt;
&lt;div class="w-full" &gt;&lt;img src="https://tanigawalab.org/publications/preprint/prism/prism-1.png" alt="PGS aggregates the genetic effects across many variants into one score." loading="lazy" data-zoomable /&gt;&lt;/div&gt;
&lt;/div&gt;&lt;/figure&gt;
Here we propose to integrate three major approaches to address the PGS transferability. We develop PRISM and apply it to 7352 fine-mapped variants from MVP, 414 ENCODE annotations, and 406,659 individuals from the UK Biobank.
&lt;figure &gt;
&lt;div class="flex justify-center "&gt;
&lt;div class="w-full" &gt;&lt;img src="https://tanigawalab.org/publications/preprint/prism/prism-2.png" alt="PRISM integrates 3 major approaches to address PGS transferability." loading="lazy" data-zoomable /&gt;&lt;/div&gt;
&lt;/div&gt;&lt;/figure&gt;
Using PRISM, we evaluated the effects of ancestry and tissue-specific integration of genomic annotations. We also compared our approach with existing methods and investigated which genomic annotation would be the most informative.
&lt;figure &gt;
&lt;div class="flex justify-center "&gt;
&lt;div class="w-full" &gt;&lt;img src="https://tanigawalab.org/publications/preprint/prism/prism-3.jpg" alt="Ancestry- and tissue-specific PRISM models" loading="lazy" data-zoomable /&gt;&lt;/div&gt;
&lt;/div&gt;&lt;/figure&gt;
We found that tissue-matched genomic annotations (from ENCODE) are most effective for enhancing PGS transferability, even though the tissue-agnostic strategy can leverage a ~18-fold larger number of genomic annotation datasets.
&lt;figure &gt;
&lt;div class="flex justify-center "&gt;
&lt;div class="w-full" &gt;&lt;img src="https://tanigawalab.org/publications/preprint/prism/prism-4.jpg" alt="Ancestry- and tissue-specific PRISM models" loading="lazy" data-zoomable /&gt;&lt;/div&gt;
&lt;/div&gt;&lt;/figure&gt;
Similarly, the use of genetic ancestry-specific fine-mapped variants is most effective, despite the power difference. Our approach offers a pragmatic solution for working with data with uneven coverage across contexts.
&lt;figure &gt;
&lt;div class="flex justify-center "&gt;
&lt;div class="w-full" &gt;&lt;img src="https://tanigawalab.org/publications/preprint/prism/prism-5.jpg" alt="Ancestry- and tissue-specific PRISM models" loading="lazy" data-zoomable /&gt;&lt;/div&gt;
&lt;/div&gt;&lt;/figure&gt;
Our benchmarking analysis shows PRISM benefits from three different strategies for enhancing PGS transferability.
&lt;figure &gt;
&lt;div class="flex justify-center "&gt;
&lt;div class="w-full" &gt;&lt;img src="https://tanigawalab.org/publications/preprint/prism/prism-6.jpg" alt="Ancestry- and tissue-specific PRISM models" loading="lazy" data-zoomable /&gt;&lt;/div&gt;
&lt;/div&gt;&lt;/figure&gt;
We showed, through feature importance analysis, that having one reference genomic annotation is not sufficient, highlighting the advantage of systematic integration with our approach.
&lt;figure &gt;
&lt;div class="flex justify-center "&gt;
&lt;div class="w-full" &gt;&lt;img src="https://tanigawalab.org/publications/preprint/prism/prism-7.jpg" alt="Ancestry- and tissue-specific PRISM models" loading="lazy" data-zoomable /&gt;&lt;/div&gt;
&lt;/div&gt;&lt;/figure&gt;
We confirm that the genetic variants selected from our approach are supported by various genomic annotations compared to other variants in LD.
&lt;figure &gt;
&lt;div class="flex justify-center "&gt;
&lt;div class="w-full" &gt;&lt;img src="https://tanigawalab.org/publications/preprint/prism/prism-8.jpg" alt="Ancestry- and tissue-specific PRISM models" loading="lazy" data-zoomable /&gt;&lt;/div&gt;
&lt;/div&gt;&lt;/figure&gt;
I am grateful to Lucy and the team for making this work possible.
&lt;figure &gt;
&lt;div class="flex justify-center "&gt;
&lt;div class="w-full" &gt;&lt;img src="https://tanigawalab.org/publications/preprint/prism/prism-9.jpg" alt="Ancestry- and tissue-specific PRISM models" loading="lazy" data-zoomable /&gt;&lt;/div&gt;
&lt;/div&gt;&lt;/figure&gt;
&lt;/p&gt;</description></item><item><title>Single-cell multiregion epigenomic rewiring in Alzheimer’s disease progression and cognitive resilience</title><link>https://tanigawalab.org/publications/2025/ad-multiregion-epigenomics/</link><pubDate>Thu, 04 Sep 2025 00:00:00 +0000</pubDate><guid>https://tanigawalab.org/publications/2025/ad-multiregion-epigenomics/</guid><description>&lt;p&gt;Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by progressive cognitive decline, yet its epigenetic underpinnings remain elusive.&lt;/p&gt;</description></item><item><title>Human microglial state dynamics in Alzheimer's disease progression</title><link>https://tanigawalab.org/publications/2023/microglia-states/</link><pubDate>Thu, 28 Sep 2023 00:00:00 +0000</pubDate><guid>https://tanigawalab.org/publications/2023/microglia-states/</guid><description>&lt;p&gt;Here we report 194,000 single-nucleus microglial transcriptomes and epigenomes across 443 human subjects and diverse Alzheimer&amp;rsquo;s disease pathological phenotypes.&lt;/p&gt;</description></item><item><title>WhichTF is dominant in your open chromatin data?</title><link>https://tanigawalab.org/publications/2022/whichtf/</link><pubDate>Tue, 30 Aug 2022 00:00:00 +0000</pubDate><guid>https://tanigawalab.org/publications/2022/whichtf/</guid><description>&lt;p&gt;We develop an ontology-guided approach to ranking tissue-/cell-type-specific transcription factors (TFs) from chromatin accessibility data.&lt;/p&gt;</description></item><item><title>SNPs2ChIP: Latent Factors of ChIP-seq to infer functions of non-coding SNPs</title><link>https://tanigawalab.org/publications/2018/snps2chip/</link><pubDate>Thu, 01 Nov 2018 00:00:00 +0000</pubDate><guid>https://tanigawalab.org/publications/2018/snps2chip/</guid><description>&lt;p&gt;We propose SNPs2ChIP, a method to infer biological functions of non-coding variants through unsupervised statistical learning methods applied to publicly-available epigenetic datasets.&lt;/p&gt;</description></item></channel></rss>